| |||||||||||||||||||||||
| |||||||||||||||||||||||
Life sciences Biotech Nysa Membrane Biotechnology startup Nysa Membrane Technologies Inc. of Burlington, Ontario, has closed a second venture round of undisclosed size. Participants in the round included Jove Investment Management, a subsidiary of Jovian Capital Corp. of Toronto, and BDC Venture Capital of Montreal. Nysa is developing membrane technology for a variety of applications, ranging from bioprocessing and bioanalytics to food and beverage uses. Nysa will use the new funds for the construction of a manufacturing facility, as well as continued product development. - P.B. Helixis Carlsbad, Calif.-based molecular diagnostic equipment developer Helixis Inc. completed a $10 million Series A funding round from Advanced Technology Ventures of Menlo Park, Calif., Okapi Venture Capital of Laguna Beach, Calif., and Domain Associates of San Diego, that will allow the new company to move technology developed at the California Institute of Technology into the market as early as 2009. The new money will support refining a manufacturing version of a completed prototype for a self-contained, portable diagnostic tool for recognizing particular DNA sequences in blood samples in research laboratories, and development of a version for use in clinical settings and the field, which will likely make use of disposable assay kits. Helixis expects to begin selling products to research labs as soon as the first quarter of 2009, with the new funding supporting the company to mid-2009 when it expects to have regulatory approval for use in medical settings. - Clifford Carlsen VC funds Carlyle Group Washington private equity fund Carlyle Group has closed a third venture fund targeting U.S.-based startups. The new $605 million vehicle, Carlyle Venture Partners III LP, follows a $602 million fund closed in 2002, and an initial $210 million fund from 1997. Carlyle now manages a total of nine venture funds including some that target European and Asian companies, as well buyout, leveraged finance and real estate funds. The firm's new U.S. fund will be used for a combination of early and expansion-stage fundings and buyouts of later-stage growth companies. Last month, an investment group controlled by the government of Abu Dhabi acquired a 7.5% stake in Carlyle Group $1.35 billion, in a deal that valued the firm at $20 billion. - P.B.  Deal Video
    Community
 Elsewhere on The Deal.comDealwatchThe Deal MagazineCorporate Dealmaker
The Deal VideoCategories
Blog roll
Archives
| |||||||||||||||||||||||
| |||||||||||||||||||||||
